Name | Type | Posted | Actions |
|---|---|---|---|
A19 Solicitation - 75D30125R00065.pdf | Jan 17, 2025 | ||
Subcontracting Plan Submission Link | LINK | Jan 17, 2025 | |
A19 Vaccine Order Limitation Chart.docx | DOCX | Jan 16, 2025 | |
A19 Authorized Distributor of Record (ADR) Agreement.docx | DOCX | Jan 16, 2025 | |
A19 Solicitation - 75D30125R00065.pdf | Jan 16, 2025 |
FY25 Vaccines for Children
Contact and place of performance
James Sprigler
Atlanta, GA 30341
USA
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA 93), guarantees f...
View moreThe Centers for Disease Control and Prevention (CDC) Office of Acquisition Services issued this combined synopsis and solicitation, numbered 75D30125R00065, to award contracts to manufacturers for the purchase of standard commercial pediatric vaccines. Established under the Vaccines for Children (VFC) program, this initiative ensures federal support for the supply of vaccines to states for eligible children aged 18 or younger, including those who are Medicaid-eligible, uninsured, American Indian or Alaska Native, or underinsured at specific health centers. The program utilizes VFC and Section 317 funds to procure vaccines at prices below commercial marketplace rates, while also allowing for the purchase of additional quantities using state and local funds for children who do not meet federal eligibility requirements.
Offerors must be manufacturers of pediatric vaccines as defined by 42 U.S.C. 1396s, which includes entities that manufacture, import, process, or distribute vaccines under their own label. This requirement is classified under NAICS 325412 for Pharmaceutical Preparation Manufacturing and PSC 6505 for Drugs and Biologicals. Performance is centered in Atlanta, Georgia, and the solicitation involves five total attachments, including a vaccine order limitation chart and an authorized distributor of record agreement.
Responses for this solicitation are due by January 30, 2025. James Sprigler serves as the primary point of contact for this requirement. The contract supports the implementation of effective immunization practices and aims to achieve higher coverage levels by providing free vaccines to participating healthcare providers through state programs.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.